Procalcitonin (PCT) and C-reactive protein (CRP) are commonly used biomarkers, but their
diagnostic advantage for neonatal early-onset (EOS) or late-onset (LOS) sepsis is …

Background Sepsis is an important cause of neonatal morbidity and mortality; therefore, the
early diagnosis of neonatal sepsis is essential. Method Our aim was to compare the …

Sepsis is one of the leading causes of mortality among critically ill patients globally.
According to WHO report 2018, it is estimated to affect beyond 30 million people worldwide …

Importance Rapid and accurate diagnosis of late-onset infection in newborn infants could
inform treatment decisions and avoid unnecessary administration of antibiotics. Objective To …

Purpose To assess the value of serum procalcitonin (PCT) for the differentiation between
patients with and without neonatal sepsis. Methods We systematically searched PubMed …

Background A number of biomarkers have been studied for the diagnosis of sepsis in
paediatrics, but no gold standard has been identified. Procalcitonin (PCT) was demonstrated …

As neonatal sepsis is a severe condition, there is a call for reliable biomarkers to
differentiate between infected and noninfected newborns. Although blood culture has been …

Neonatal sepsis is a bacterial bloodstream infection leading to severe clinical manifestations
frequently associated with death or irreversible long-term deficits. Antibiotics are the drug of …

Background Neonatal infections annually claim lives of 1.4 million neonates worldwide. Until
now, there is no ideal diagnostic test for detecting sepsis and thus management of possible …

Background: Late-onset sepsis is an important cause of morbidity and mortality in infants.
Diagnosis of late-onset sepsis can be challenging. The complete blood cell count and …